LM22A-4
10mM in DMSO
- Product Code: 201868
CAS:
37988-18-4
| Molecular Weight: | 339.34 g./mol | Molecular Formula: | C₁₅H₂₁N₃O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
LM22A-4 is a small molecule agonist of the TrkB receptor, which plays a key role in neuronal survival, growth, and synaptic plasticity. It is primarily investigated for its neuroprotective and neurorestorative properties. The compound has shown potential in preclinical studies for treating neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and Huntington's disease by enhancing brain-derived neurotrophic factor (BDNF) signaling pathways. It has also been studied in models of traumatic brain injury and stroke, where it helps reduce neuronal damage and improve cognitive and motor functions. Due to its ability to cross the blood-brain barrier, LM22A-4 is considered a promising candidate for central nervous system therapeutics. Research is ongoing to evaluate its efficacy and safety in chronic neurological disorders.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿2,780.00 |
+
-
|
LM22A-4
LM22A-4 is a small molecule agonist of the TrkB receptor, which plays a key role in neuronal survival, growth, and synaptic plasticity. It is primarily investigated for its neuroprotective and neurorestorative properties. The compound has shown potential in preclinical studies for treating neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and Huntington's disease by enhancing brain-derived neurotrophic factor (BDNF) signaling pathways. It has also been studied in models of traumatic brain injury and stroke, where it helps reduce neuronal damage and improve cognitive and motor functions. Due to its ability to cross the blood-brain barrier, LM22A-4 is considered a promising candidate for central nervous system therapeutics. Research is ongoing to evaluate its efficacy and safety in chronic neurological disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :